Olfaction and cardiovascular risk: a connection yet to be explored

Authors

  • Carlota Sousa Unidade Local de Saúde Lisboa Ocidental, Lisboa, Portugal https://orcid.org/0009-0002-2905-1496
  • Joana Guincho Unidade Local de Saúde Lisboa Ocidental, Lisboa, Portugal
  • Luís Baptista Unidade Local de Saúde Lisboa Ocidental, Lisboa, Portugal
  • Filipe Correia Unidade Local de Saúde Lisboa Ocidental, Lisboa, Portugal
  • Mariana Donato Unidade Local de Saúde Lisboa Ocidental, Lisboa, Portugal
  • Pedro Escada Unidade Local de Saúde Lisboa Ocidental, Lisboa, Portugal

DOI:

https://doi.org/10.34631/sporl.3114

Keywords:

Smell, cardiovascular disease

Abstract

Introduction: Cardiovascular disease (CVD) is highly prevalent in the general population, especially in older age groups. Published studies associate loss of smell with comorbidities such as dyslipidemia, stroke, and heart failure. However, results are inconsistent, and the relationship between CVD and olfactory dysfunction remains unclear.
Objective: To evaluate the correlation between loss of smell, cardiovascular risk factors (CVRFs), and overall cardiovascular risk (CVR).
Material and methods: A retrospective study design, recruiting patients aged 40 years and older, observed on our Olfaction Clinic at a tertiary hospital between 2016 and 2024. CVRFs (sex, age, systolic blood pressure, total and HDL cholesterol, weight, height, smoking habits, and the presence of diabetes mellitus (DM)) were assessed. The degree of loss of smell was quantified using the Burghart Sniffin' Sticks Identification Test (0-16). CVR was calculated using the SCORE2, SCORE2-OP (patients >70 years), and SCORE2-DM (diabetic patients). A case-control study and correlation analysis between the identification score and the other variables were performed. The control group included age- and sex-matched individuals with no subjective loss of smell. Statistical analysis was performed using SPSS® 30.0 for MacOs.
Results: 119 patients were included (81 with changed sense of smell and 38 in the control group). The mean age was 61 ± 11 years, 79 were female; 16.8% had diabetes. The study group had a mean olfactory identification score of 8.4 ± 4 and a mean CVR of 7.7% ± 6%.Our results showed that our patients with olfactory dysfunction have significantly higher total cholesterol levels and a greater tendency to DM (p = 0.054), although this was not statistically significant. When subgroup analysis was applied and patients with smell loss due to sinonasal pathology were excluded, a statistically significant relationship was found between smell identification results and CVR (p = 0.031), as well as with total cholesterol (p = 0.044). No other statistically significant associations were found in the other variables evaluated.
Conclusion: This is the first study to explore the relationship between CVR and smell disorders in the Brazilian population. This study suggests an association between smell loss, elevated serum cholesterol, and increased CVR.

Downloads

Download data is not yet available.

References

Roh D, Lee DH, Kim SW, Kim SW, Kim BG, Kim DH. et al. The association between olfactory dysfunction and cardiovascular disease and its risk factors in middle-aged and older adults. Sci Rep. 2021 Jan 13;11(1):1248. doi: 10.1038/s41598-020-80943-5.

Wehling E, Naess H, Wollschlaeger D, Hofstad H, Bramerson A, Bende M. et al. Olfactory dysfunction in chronic stroke patients. BMC Neurol. 2015 Oct 12:15:199. doi: 10.1186/s12883-015-0463-5.

Chamberlin KW, Yuan Y, Li C, Luo Z, Reeves M, Kucharska-Newton A. et al. Olfactory impairment and the risk of major adverse cardiovascular outcomes in older adults. J Am Heart Assoc. 2024 Jun 18;13(12):e033320. doi: 10.1161/JAHA.123.033320.

Liu G, Zong G, Doty RL, Sun Q. Prevalence and risk factors of taste and smell impairment in a nationwide representative sample of the US population: a cross-sectional study. BMJ Open. 2016 Nov 9;6(11):e013246. doi: 10.1136/bmjopen-2016-013246.

Task Force Members, Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C. et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol. 2016 Jul;23(11):NP1-NP96. doi: 10.1177/2047487316653709

Desiato VM, Levy DA, Byun YJ, Nguyen SA, Soler ZM, Schlosser RJ. The prevalence of olfactory dysfunction in the general population: a systematic review and meta-analysis. Am J Rhinol Allergy. 2021 Mar;35(2):195-205. doi: 10.1177/1945892420946254.

Frasnelli J, Lundström JN, Boyle JA, Djordjevic J, Zatorre RJ, Jones-Gotman M. Neuroanatomical correlates of olfactory performance. Exp Brain Res. 2010 Feb;201(1):1-11. doi: 10.1007/s00221-009-1999-7.

Cardella A, Ferrulli A, Vujosevic S, Preti A, Ambrogi F, Terruzzi I. et al. Olfactory dysfunction in patients with type 2 diabetes mellitus. Rhinology. 2024 Oct 1;62(5):537-547. doi: 10.4193/Rhin23.451.

Published

2025-09-13

How to Cite

Sousa, C., Guincho, J., Baptista, L., Correia, F., Donato, M., & Escada, P. (2025). Olfaction and cardiovascular risk: a connection yet to be explored. Portuguese Journal of Otorhinolaryngology and Head and Neck Surgery, 63(3), 295–301. https://doi.org/10.34631/sporl.3114

Issue

Section

Original Article